Alder har ingen klinisk relevant effekt på nicotinsyres (depotformulering) farmakokinetik på basis af en sammensat analyse af personer i alderen 18- 65 år.
Age has no clinically meaningful effect on pharmacokinetics of nicotinic acid (prolonged-release formulation) based on a composite analysis of subjects ages 18-65 years.